are non-cancerous, hormonally-responsive muscle tissue tumors of the uterus.1 They can affect up to 70% of Caucasian women and up to 80% of African American women by age 50.2 Fibroids can be asymptomatic but, in some women, fibroids can cause symptoms, such as heavy menstrual bleeding (HMB), vaginal bleeding at times other than menstruation, and anemia.1,3
How prevalent are uterine fibroids
, and what are their effects on quality of life?
This Market Spotlight report covers the Uterine Fibroids
market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of success, regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals.
However, past research suggests that US women, a majority of who will experience uterine fibroids
by the age of 50, are largely unaware of the UFE.
affect 7080% of women under the age of 55.
are tumors found within the uterine walls, often resulting in a change to the uterus' size and/or shape.
Women attending the gynaecology outpatient clinic at Aga Khan University Hospital, Nairobi, and having a diagnosis of symptomatic uterine fibroids
, were given written information about UAE.
The principle of HIFU treatment of uterine fibroids
is that focused ultrasonic energy causes coagulative necrosis of the target.
There is very little evidence on the comparative efficacy of uterine fibroid
treatment options so the COMPARE-UF (Comparing Options for Management: Patient-Centered Results for Uterine Fibroids
) registry was initiated for women who choose procedural therapy for symptomatic uterine fibroids
Relugolix is being developed as a gonadotropin-releasing receptor antagonist to be taken orally once daily against uterine fibroids
, endometriosis and prostate cancer.
THURSDAY, April 12, 2018 (HealthDay News) -- For women undergoing hysterectomy for uterine fibroids
, there was an increase in major and minor 30-day complication rates following the issuing of a U.S.
The prevalence of uterine fibroids
in pregnancy varies between 1.6 and 10.7 percent, depending upon the trimester of assessment and the size threshold.1-5 There is a plethora of publications in the medical literature and textbook chapters on the gynaecological aspects of fibroid outside of pregnancy, but the literature is scanty and conflicting on the fibroid features and management during pregnancy and labour.